Mazyar Shadman, Jennifer Brown, David Campbell, Mei Xue, Marjan Massoudi, Rhys Williams, Keri Yang, Constantine Tam. "Number needed to treat to avoid progression or death: Zanubrutinib vs other COVALENT bruton tyrosine kinase inhibitors in Relapsed/Refractory chronic lymphocytic leukemia." Blood, 2025. doi:10.1182/blood-2025-4553